Clockwork Bio
Clockwork Bio develops AI-driven solutions to generate high-quality oncology data assets for use in drug development. Its mission is to advance the industrialization of the drug development pipeline to help create a world without cancer.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology Research
- Founded
- 2025
- Employees
- 4
- Founders
- Shane Lewin, Nick Peterson
Is this your organization? Claim it
Nick Peterson of Clockwork Bio argues legacy knowledge graphs failed but can be rebuilt for agentic AI–driven target discovery
Nick Peterson argues that traditional biotech knowledge graphs have fallen short of transforming target discovery but contends that, with a fundamental rethink aligned to agentic AI systems, knowledge graphs can finally become indispensable for understanding complex, context-dependent biological mechanisms.
Shane Lewin announces Clockwork Bio, an AI-native platform to automate pre-clinical oncology discovery
Shane Lewin announces Clockwork Bio, an AI-native platform aiming to automate and scale pre-clinical oncology discovery by using active learning, AI phenotyping, and emerging modalities to probe and control cell states and accelerate target identification.
People
-
Nick Peterson Co-Founder and CTO